Emerald updates its previously issued FY25 guidance range to $460M-$465M in revenue and $122.5M-$127.5M in Adjusted EBITDA, from its prior range of $450M-$460M in Revenue and $120M-$125M in Adjusted EBITDA, to reflect the acquisition of Generis.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EEX: